Announced positive interim clinical results of 32 patients for XFLO™ Minimally Invasive BPH Treatment Device
Delta Asia International Co. publicly listed (IPO) on Taipei Exchange, stock ticker: 6762
Received the milestone payment of $2.5 million from Terumo upon successful verification and technology transfer of Cross-Seal
Successful secondary public offering (SPO) at Taipei Exchange
Delta Asia International Co. trading on Emerging Stock Board of Taipei Exchange, stock ticker: 6762
Entered into an Asset Purchase Agreement with Terumo for XPro™ System (IVC-C01, now Cross-Seal™) Large Bore Suture-Mediated Vascular Closure Device
Panther Orthopedics, Inc. Received FDA 510(k) Clearance for the PUMA™ System
Invested in Aquedeon Medical to develop the thoracic aortic repair device
Successful clinical use of the PUMA™ System of Panther Orthopedics, Inc.
Invested in Panther Orthopedics to develop PUMA™ System, the novel “dynamic fixation” solution to treat orthopedic extremity injuries
Incepted the CE studies for XPro™ System (IVC-C01, now Cross-Seal™) Large Bore Suture-Mediated Vascular Closure Device
Publicly listed (IPO) on Taipei Exchange, stock ticker: 6499
U.S. Food and Drug Administration 510(k) clearance for AbClose™(LAP-C01) Trocar Wound Closure Device
Invested in Prodeon to develop the Mercury Project (URO-T01) for treatment of Benign Prostatic Hyperplasia (BPH)
Invested in Delta Asia International Co. to enrich manufacturing capability
U.S. Food and Drug Administration 510(k) clearance for ClickClean™ (LAP-A01) Laparoscope Lens Shield Device
Successful First-in-Man Studies for XPro™ (IVC-C01, now Cross-Seal™) Large Bore Suture-Mediated Vascular Closure Device
Turned public in compliance with regulations governed by Securities and Futures Bureau of Financial Supervisory Committee
Stock trading on Emerging Stock Board of Taipei Exchange, stock ticker: 6499
Became eligible for tax incentives programs under the Act for the Development of Biotech and New Pharmaceutical Industry, Minister of Economic Affairs
Company inception